跳至主要内容
临床试验/KCT0000757
KCT0000757招募中未知

Effects of Ticagrelor and intracoronary morphine on Myocardial Salvage in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Samsung Medical Center0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • 1.General inclusion criteria
  • -Subject must be at least 20 years of age.
  • -Patients undergoing primary PCI for STEMI
  • -Diagnosis of STEMI: ST-segment elevation >0.1 millivolt in =2 contiguous leads or (presumably) new left bundle branch block
  • -Presence of symptoms less than 12 hours
  • 2.Additional inclusion criteria for intracoronary morphine
  • -TIMI flow grade 0 or 1 of infarct related arteries

排除标准

  • 3.Exclusion Criteria:
  • - Known hypersensitivity or contraindication to study medications or contrast
  • - Female of childbearing potential, unless a recent pregnancy test is negative, who possibly plan to become pregnant any time after enrollment into this study.
  • - Rescue PCI after thrombolysis or facilitated PCI
  • - Cardiogenic shock or cardiopulmonary resuscitation before randomizatio
  • - Known chronic hepatic disease
  • - Known renal dysfunction (creatinine level 3.0mg/dL or dependence on dialysis).
  • - Decompensated chronic obstructive pulmonary disease or active asthma at inclusion
  • - Mechanical ventilation at inclusion
  • - Brain injury or intracranial hypertension
  • - Acute alcohol intoxication
  • - Known ulcerative colitis
  • - Active epilepsy
  • - Contraindications to undergo MRI imaging include any of the following
  • : A cardiac pacemaker or implantable defibrillator; any implanted or magnetically activated device; or any history indicating contraindication to MRI including claustrophobia or allergy to gadolinium
  • - Current use of oral anticoagulant
  • - An increased risk of bradycardia
  • :Sinus node dysfunction, atrioventricular dysfunction, or heart rate <40/min
  • - Patients receiving clopidogrel 300 mg or more before randomization
  • - One of followings
  • :1)history of intracranial bleeding
  • 2)intracranial tumor, arteriovenous malformation or aneurysm
  • 3)stroke within past 3 months
  • - Active bleeding of internal organ or bleeding diathesis
  • - Acute aortic dissection

研究者

相似试验